Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

101.40p
   
  • Change Today:
    -0.40p
  • 52 Week High: 110.00p
  • 52 Week Low: 73.40p
  • Currency: UK Pounds
  • Shares Issued: 536.76m
  • Volume: 162,110
  • Market Cap: £544.27m
  • RiskGrade: 119
  • Beta: 0.27

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 101.40p per share. In the last year Alliance Pharma's share price has ranged from 73.40p to 110.00p and brokers are currently rating this stock as 'strong buy'.
Registrars: Capita Registrars

Key Personnel

CEO: Peter Butterfield
CFO: Andrew Franklin
Company Secretary: Rob Bellhouse
Independent Non-Executive Director: Jo Le Couilliard
Independent Non-Executive Director: Richard Jones
Non-Executive Chairman: David Cook
Non-Executive Dir:

Contact Details

Address: Avonbridge House,Bath Road, Chippenham, Wiltshire, SN15 2BB
Website: http://www.alliancepharma.co.uk

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-ShareFTSE AIM 50FTSE AIM 100
ISIN: GB0031030819

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 101.40p
Change Today -0.40p
% Change -0.39 %
52 Week High 110.00p
52 Week Low 73.40p
Volume 162,110
Shares Issued 536.76m
Market Cap £544.27m
Beta 0.27
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.09% below the market average86.09% below the market average86.09% below the market average86.09% below the market average86.09% below the market average
12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average
Price Trend
59.48% above the market average59.48% above the market average59.48% above the market average59.48% above the market average59.48% above the market average
34.43% above the sector average34.43% above the sector average34.43% above the sector average34.43% above the sector average34.43% above the sector average
Income
47.76% below the market average47.76% below the market average47.76% below the market average47.76% below the market average47.76% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Growth
12.55% below the market average12.55% below the market average12.55% below the market average12.55% below the market average12.55% below the market average
94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 16-Dec-21 10-Jun-21
Paid 07-Jan-22 08-Jul-21
Amount 0.56p 1.07p

Trades for 29-Nov-2021

Time Volume / Share Price
13:24 2 @ 101.09p
13:15 11,400 @ 101.44p
13:09 11,000 @ 101.19p
12:51 498 @ 101.40p
12:51 13 @ 101.40p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page